Product IntroductionBioactivity英文名:
CS1描述: CS1 是一种有效的DNA Topo II 抑制剂。CS1 显示出广谱的体外抗肿瘤作用、体内低毒性和潜在的抗多药耐药能力。CS1 导致 DNA 损伤、细胞周期停滞在 G2/M 期和细胞凋亡。
体外活性: CS1 has cytotoxicity with IC 50 values of 16.92 and 18.88 μM for MCF-7 and MCF7/ADR cells, respectively [1]. CS1 (10, 50, 100 μM) inhibits the topoisomerase II α (Topo IIα) activity [1]. CS1 (0-20 μM) shows antiproliferation activity in cancer cells [1]. CS1 (2.5, 5, 10 μM) induces cell cycle arrest at the G2/M phase [1]. CS1 (2.5, 5, 10 μM) induces cell apoptosis [1]. CS1 (5, 10, 15 μM; 24 h) induces DNA breaks in MDA-MB-231 cells [1]. Cell Cycle Analysis [1] Cell Line: MDA-MB-231 cells Concentration: 2.5, 5, 10 μM Incubation Time: Result: Cells were arrest at the G2/M phase. Apoptosis Analysis [1] Cell Line: MDA-MB-231 cells Concentration: 2.5, 5, 10 μM Incubation Time: Result: Induced apoptosis
体内活性: CS1 (20 mg/kg; i.v.; every other day for two weeks) has antitumor effects [1]. Animal Model: Five-week-old female athymic nude mice (BALB/c-nu) [1] Dosage: 20 mg/kg Administration: i.v., every other day for two weeks Result: Showed antitumor effects.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year